Clinical Trial

To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 11, 2025 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Phase 1 study to assess the pharmacokinetic availability and safety and tolerability profile of one such ayurvedic preparation which contains 5 mg THC:CBD 1:1 preparation. Other than the PK profile, we will also be studying its effect on gene expression profiling of the breast and head neck oral cavity squamous cell carcinoma tissue.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-07-22; most recent amendment 2025-04-08.
Trial Details
NCT Number NCT05969314
Lead Sponsor Tata Memorial Hospital
Conditions Breast Cancer, Oral Cancer
Enrollment 12 participants
Start Date 2022-06-08
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-11